Nocturnal hypoventilation in neuromuscular disease: prevalence according to different definitions issued from the literature

[1]  G. Barton,et al.  Randomised controlled trial , 2016 .

[2]  L. Aboussouan.  Sleep-disordered Breathing in Neuromuscular Disease. , 2015, American journal of respiratory and critical care medicine.

[3]  D. Annane,et al.  Nocturnal mechanical ventilation for chronic hypoventilation in patients with neuromuscular and chest wall disorders. , 2014, The Cochrane database of systematic reviews.

[4]  A. Simonds.  Chronic hypoventilation and its management , 2013, European Respiratory Review.

[5]  J. Bach,et al.  Changing Trends in the Management of End-Stage Neuromuscular Respiratory Muscle Failure: Recommendations of an International Consensus , 2013, American journal of physical medicine & rehabilitation.

[6]  S. Quan,et al.  Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. , 2012, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[7]  D. Orlikowski,et al.  Nocturnal Oximetry and Transcutaneous Carbon Dioxide in Home-Ventilated Neuromuscular Patients , 2012, Respiratory Care.

[8]  R. Pierce,et al.  Transcutaneous Measurement of Carbon Dioxide Tension During Extended Monitoring: Evaluation of Accuracy and Stability, and an Algorithm for Correcting Calibration Drift , 2011, Respiratory Care.

[9]  J. Pépin,et al.  Nocturnal monitoring of home non-invasive ventilation: the contribution of simple tools such as pulse oximetry, capnography, built-in ventilator software and autonomic markers of sleep fragmentation , 2010, Thorax.

[10]  D. Miedinger,et al.  Comparison of combined oximetry and cutaneous capnography using a digital sensor with arterial blood gas analysis , 2010, Scandinavian journal of clinical and laboratory investigation.

[11]  J. Geddes,et al.  What is a randomised controlled trial? , 2009, Epidemiologia e Psichiatria Sociale.

[12]  K. Bushby,et al.  EFNS guideline on diagnosis and management of limb girdle muscular dystrophies , 2007, European journal of neurology.

[13]  G. Levy,et al.  The changing natural history of spinal muscular atrophy type 1 , 2007, Neurology.

[14]  P. Shaw,et al.  Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial , 2006, The Lancet Neurology.

[15]  A K Simonds,et al.  Randomised controlled trial of non-invasive ventilation (NIV) for nocturnal hypoventilation in neuromuscular and chest wall disease patients with daytime normocapnia , 2005, Thorax.

[16]  K. Bloch,et al.  Monitoring carbon dioxide tension and arterial oxygen saturation by a single earlobe sensor in patients with critical illness or sleep apnea. , 2005, Chest.

[17]  A. Simonds,et al.  Mechanisms of improvement of respiratory failure in patients with restrictive thoracic disease treated with non-invasive ventilation , 2005, Thorax.

[18]  Colin Chandler,et al.  Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation , 2002, Neuromuscular Disorders.

[19]  M. Naumann,et al.  Disease progression in amyotrophic lateral sclerosis: Predictors of survival , 2002, Muscle & nerve.

[20]  C. Guilleminault,et al.  Sleep-disordered breathing in neuromuscular disease , 2002, Current treatment options in neurology.

[21]  R. Barohn,et al.  A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patients , 2001, Journal of the Neurological Sciences.

[22]  M. Polkey,et al.  Respiratory aspects of neurological disease , 1999, Journal of neurology, neurosurgery, and psychiatry.

[23]  A. Simonds,et al.  Impact of nasal ventilation on survival in hypercapnic Duchenne muscular dystrophy , 1998, Thorax.

[24]  M. Luís,et al.  Respiratory assistance with a non-invasive ventilator (Bipap) in MND/ALS patients: Survival rates in a controlled trial , 1995, Journal of the Neurological Sciences.

[25]  S. Chevret,et al.  Randomised trial of preventive nasal ventilation in Duchenne muscular dystrophy , 1994, The Lancet.

[26]  K. Rimmer,et al.  Myotonia of the respiratory muscles in myotonic dystrophy. , 1993, The American review of respiratory disease.

[27]  E. Fletcher,et al.  Evolution of nocturnal oxyhemoglobin desaturation in patients with chronic obstructive pulmonary disease and a daytime PaO2 above 60 mm Hg. , 1991, The American review of respiratory disease.

[28]  T. Takishima,et al.  Respiratory muscle strength and gas exchange in neuromuscular diseases: comparison with chronic pulmonary emphysema and idiopathic pulmonary fibrosis. , 1989, The Tohoku journal of experimental medicine.

[29]  A. Ries.  Oximetry--know thy limits. , 1987, Chest.

[30]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[31]  F. Magnet,et al.  Transcutaneous monitoring as a replacement for arterial PCO(2) monitoring during nocturnal non-invasive ventilation. , 2011, Respiratory medicine.

[32]  D. Hillman,et al.  Daytime predictors of sleep hypoventilation in Duchenne muscular dystrophy. , 2000, American journal of respiratory and critical care medicine.

[33]  Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation--a consensus conference report. , 1999, Chest.